© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Genitourinary Syndrome of Menopause (GSM): Clinical FAQ for Primary Care
October 31st 2025
The Menopause Society Annual Meeting
Genitourinary symptoms of menopause often are ignored--by patients and practitioners alike. Primary care clinicians are in a key position to identify, educate, and initiate treatment.
Screening for Breast Cancer in Patients With Dense Breast Tissue: A Q&A With Donna Plecha, MD
October 31st 2025
The Menopause Society Annual Meeting
TMS 2025: Donna Plecha, MD, discusses how primary care physicians should approach breast cancer screening in women with dense breasts and use MRI effectively.
Hormone Therapy and Autoimmune Disease Risk in Postmenopausal Women, With Xuezhi Daniel Jiang, MD, PhD
October 30th 2025
The Menopause Society Annual Meeting
TMS 2025: Jiang explains why he investigated hormone therapy's effect on autoimmune disease risk in postmenopausal women.
Inequities in MHT Prescribing Run Deep: A Conversation With Wake Forest's Anna Christine Cochrane, MD
October 30th 2025
The Menopause Society Annual Meeting
TMS 2025: Cochrane explains the impetus behind 2 studies she has authored on the patient- and provider-level factors that influence MHT prescribing.
MHT and Alzheimer Risk: New Evidence for a Critical Window, with Roksana Karim, MD, PhD
October 29th 2025
The Menopause Society Annual Meeting
Karim discusses secondary findings from the ELITE trial of timing for estradiol initiation, which reveal a notable impact on Aβ biomarkers of Alzheimer disease.
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
October 28th 2025
The Menopause Society Annual Meeting
Menopause specialist Caroline Mitchell, MD, MPH, explains the dual nature of the breakdown in communication that can leave women virtually uninformed about GSM and treatment.
Estetrol Phase 3 Trial Shows No Impact on Postmenopausal BP, Even in Women at High CV Risk
October 27th 2025
The Menopause Society Annual Meeting
The phase 3 E4COMFORT II trial found no impact on BP after 1 year of treatment in postmenopausal women with elevated HbA1c, lipids, and TGs.
Caroline Mitchell, MD, Describes Toll of Genitourinary Syndrome of Menopause on QoL
October 27th 2025
The Menopause Society Annual Meeting
TMS: Half of postmenopausal women suffer from GSM, yet only 25% seek treatment. Mitchell, an expert in vulvovaginal health, explains the gap and its impact on women.